NCT00004141View on ClinicalTrials.gov

Combination Chemotherapy Plus Biological Therapy in Treating Patients With Metastatic Melanoma

PHASE2CompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

August 31, 1998

Primary Completion Date

January 31, 2003

Study Completion Date

April 30, 2006

Conditions
Melanoma (Skin)
Interventions
DRUG

Cisplatin

DRUG

dacarbazine

DRUG

Granulocyte-macrophage colony-stimulating factor

Trial Locations (1)

60637-1470

University of Chicago Cancer Research Center, Chicago

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Chicago

OTHER

NCT00004141 - Combination Chemotherapy Plus Biological Therapy in Treating Patients With Metastatic Melanoma | Biotech Hunter | Biotech Hunter